Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents With Attention Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse.
This study ended early.
In The Hague
Preference and Goal-Directed Primary Care to Minimize Disparities and Improve Outcomes in ADHD
This study has finished and is no longer accepting participants.
In Philadelphia
Psychoeducational Groups for Adults With Attention-Deficit Hyperactivity/Impulsivity Disorder (ADHD): a Randomized Waitlist-controlled Multicenter Pilot Trial
This study has finished and is no longer accepting participants.
Multiple locations, including LevangerQuality Assurance of Administering Methylphenidate in Adults With ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including Bad WildungenResearching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder - a Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In HamburgResponse Variability in Children With ADHD
This study has finished and is no longer accepting participants.
In CincinnatiThe Effect of Reward on Cognitive Functioning, Motor Skills, and Motivation in 8- to 10-Year-Old Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In KaunasA Double-Blind, Randomized, Placebo-Controlled, Multicenter, Fixed Dose Study to Assess Efficacy, Safety, and Tolerability of TC-5619 in Adults With Inattentive-Predominant Attention Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including Beverly HillsAn Open-label, Randomized, Rater-blinded, Cross-over, Multicenter Study Comparing the Clinical Efficacy of Methylphenidate (Immediate Release/Extended Release) Treatment (20 or 40 mg Orally od) in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Under Different Breakfast Conditions Over Two Weeks
This study has finished and is no longer accepting participants.
In Freiburg im BreisgauAn Open-Label, Multicenter, Pilot Study of the Safety and Efficacy of Transitioning From a Stimulant Medication to Atomoxetine in Pediatric and Adolescent Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In St LouisResearchers compared SPD489 (Lisdexamfetamine dimesylate) and placebo, tracking side effects to assess safety in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared ABT-089 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.